HiveProspectStranded Biotech Asset IntelligenceResearch intelligence
Research workspace tools

PPM-204

TERMINATED · PHASE2 · Diabetes Mellitus

Study terminated as a result of interim analysis not meeting predetermined criteria.

Registry source

Scientific benefit, asset-specific safety, ownership and licensing: Unknown without reviewed evidence.

Detailed evidence is available in the local Pro plan simulation.